Author

John Mathews

Institutions: Medical City Dallas Hospital, HCA Healthcare, Sarah Cannon

Observed institutions: Medical City Dallas Hospital, HCA Healthcare, Sarah Cannon

OpenAlex ID: A5126887139

Outpatient Versus Inpatient Axicabtagene Ciloleucel CAR T-Cell Therapy in Non-Hodgkin’s Lymphoma: Insights From A US Multicenter Transplant and Cellular Therapy Network

2026 · Minoo Battiwalla, Shanna Arnold Egloff, et al. · Transplantation and Cellular Therapy · 1

Improved outcomes with TKI maintenance after brexucabtagene autoleucel in Philadelphia chromosome ALL

2026 · Tamer Othman, Gregory W. Roloff, et al. · Blood Advances

Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)

2025 · Rawan Faramand, Gregory Roloff, et al. · Transplantation and Cellular Therapy

Works count: 3

Citation count: 1

H-index: 1

I10-index: